p53 in survival, death and metabolichealth: a lifeguard with a licence to kill, Nature Reviews Molecular Cell Biology, vol.16, issue.7, pp.393-405, 2015. ,
Control of metabolism by p53-Cancer and beyond, Biochimica et Biophysica Acta (BBA) -Reviews on Cancer, vol.1870, issue.1, pp.32-42, 2018. ,
Regulation of metabolic activity by p53, Metabolites, vol.7, issue.2, p.21, 2017. ,
Tumor suppressor p53 and metabolism, Journal of Molecular Cell Biology, vol.11, issue.4, pp.284-292, 2018. ,
Control of nucleotide metabolism enables mutant p53's oncogenic gain-of-function activity, International Journal of Molecular Sciences, vol.18, issue.12, p.2759, 2017. ,
Wild-type and mutant p53 protein in mitochondrial dysfunction: emerging insights in cancer disease, Seminars in Cell & Developmental Biology, vol.18, pp.30163-30170, 2019. ,
Mutant p53 and cellular stress pathways: a criminal alliance that promotes cancer progression, Cancers, vol.11, issue.5, p.614, 2019. ,
TP53 mutation, mitochondria and cancer, Current Opinion in Genetics & Development, vol.38, pp.16-22, 2016. ,
The tumor suppressor p53 downregulates glucose transporters GLUT1 and GLUT4 gene expression, Cancer Research, vol.64, issue.7, pp.2627-2633, 2004. ,
p53 regulates glucose metabolism through an IKK-NF-kB pathway and inhibits cell transformation, Nature Cell Biology, vol.10, issue.5, pp.611-618, 2008. ,
Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors, Cancer Research, vol.72, issue.4, pp.939-948, 2012. ,
TIGAR, a p53-inducible regulator of glycolysis and apoptosis, Cell, vol.126, issue.1, pp.107-120, 2006. ,
Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD, Oncotarget, vol.5, issue.14, pp.5535-5546, 2014. ,
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells, Oncogene, vol.36, issue.23, pp.3287-3299, 2017. ,
p53 coordinates DNA repair with nucleotide synthesis by suppressing PFKFB3 expression and promoting the pentose phosphate pathway, Scientific Reports, vol.6, p.38067, 2016. ,
lates glucose metabolism by miR-34a, Biochemical and Biophysical Research Communications, vol.437, issue.2, pp.225-231, 2013. ,
Glycolytic enzymes can modulate cellular life span, Cancer Research, vol.65, issue.1, pp.177-185, 2005. ,
p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2, Cancer Research, vol.72, issue.2, pp.560-567, 2012. ,
a-Ketoglutarate links p53 to cell fate during tumour suppression, Nature, 2019. ,
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species, Proceedings of the National Academy of Sciences, vol.107, issue.16, pp.7461-7466, 2010. ,
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function, Proceedings of the National Academy of Sciences, vol.107, issue.16, pp.7455-7460, 2010. ,
Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation, Proceedings of the National Academy of Sciences, vol.11, issue.23, pp.2414-2422, 2014. ,
ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress, Molecular Cell, vol.44, issue.3, pp.491-501, 2011. ,
Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model, Cell Death & Differentiation, vol.20, issue.4, pp.659-668, 2013. ,
Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function, Cell Reports, vol.10, issue.7, pp.1096-1109, 2015. ,
regulates mitochondrial respiration, Science, vol.312, issue.5780, pp.1650-1653, 2006. ,
p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content, Circulation Research, vol.105, issue.7, pp.705-712, 2009. ,
Regulation of AIF expression by p53, Cell Death & Differentiation, vol.13, issue.12, pp.2140-2149, 2006. ,
Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma, The EMBO Journal, vol.24, pp.3482-3492, 2005. ,
Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53, Nucleic Acids Research, vol.37, issue.2, pp.568-581, 2008. ,
P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA, Cancer Research, vol.63, issue.13, pp.3729-3734, 2003. ,
p53 in mitochondria enhances the accuracy of DNA synthesis, Cell Death & Differentiation, vol.15, issue.12, pp.1865-1874, 2008. ,
Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F?F?-ATP synthase, Cell Cycle, vol.12, issue.17, pp.2781-2793, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01871462
Effect of p53 on mitochondrial morphology, import, and assembly in skeletal muscle, The Australian Journal of Pharmacy: Cell Physiology, vol.308, issue.4, pp.319-329, 2015. ,
p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers, Journal of Biological Chemistry, vol.289, issue.39, pp.27134-27145, 2014. ,
miR-30 regulates mitochondrial fission through targeting p53 and the dynaminrelated protein-1 pathway, PLoS Genetics, vol.6, issue.1, p.1000795, 2010. ,
miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1, Nature Medicine, vol.17, issue.1, pp.71-78, 2010. ,
Mieap, a p53-inducible protein, controls mitochondrial quality by repairing or eliminating unhealthy mitochondria, PLoS One, vol.6, issue.1, p.16060, 2011. ,
Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses, Genes & Development, vol.27, issue.9, pp.1016-1031, 2013. ,
Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect, Proceedings of the National Academy of Sciences, vol.108, issue.39, pp.16259-16264, 2011. ,
Possible existence of lysosome-like organella within mitochondria and its role in mitochondrial quality control, PLoS One, vol.6, issue.1, p.16054, 2011. ,
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase, Nature Cell Biology, vol.13, issue.3, pp.310-316, 2011. ,
Regulation of lipid metabolism by p53 e fighting two villains with one sword, Trends in Endocrinology and Metabolism, vol.23, issue.11, pp.567-575, 2012. ,
p53 as a regulator of lipid metabolism in cancer, International Journal of Molecular Sciences, vol.17, issue.12, p.2074, 2016. ,
p53 represses the mevalonate pathway to mediate tumor suppression, Cell, vol.176, issue.3, pp.564-580, 2018. ,
Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence, Nature, vol.493, issue.7434, pp.689-693, 2013. ,
p53-inducible DHRS3 is an endoplasmic reticulum protein associated with lipid droplet accumulation, Journal of Biological Chemistry, vol.286, issue.32, pp.28343-28356, 2011. ,
The retinal dehydrogenase/reductase retSDR1/DHRS3gene is activated by p53 and p63 but not by mutants derived from tumors or EEC/ADULT malformation syndromes, Cell Cycle, vol.9, issue.11, pp.2177-2188, 2014. ,
Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression, Oncogene, vol.22, issue.23, pp.3645-3654, 2003. ,
p53 attenuates AKT signaling by modulating membrane phospholipid composition, Oncotarget, vol.6, issue.25, pp.21240-21254, 2015. ,
Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53, PLoS Genetics, vol.11, issue.3, p.1005053, 2015. ,
Mitochondrial dysfunction contributes to oncogene-induced senescence, Molecular and Cellular Biology, vol.29, issue.16, pp.4495-4507, 2009. ,
Oncogene-induced senescence results in marked metabolic and bioenergetic alterations, Cell Cycle, vol.11, issue.7, pp.1383-1392, 2012. ,
p53, a novel regulator of lipid metabolism pathways, Journal of Hepatology, vol.56, issue.3, pp.656-662, 2012. ,
GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress, Molecular Cell, vol.36, issue.3, pp.379-392, 2009. ,
Ceramide signaling and p53 pathways, Advances in Cancer Research, vol.140, pp.191-215, 2018. ,
Down-regulation of sphingosine kinase-1 by DNA damage, Journal of Biological Chemistry, vol.279, pp.20546-20554, 2004. ,
Defining a role for sphingosine kinase 1 in p53-dependent tumors, Oncogene, vol.31, issue.9, pp.1166-1175, 2011. ,
CerS6Is a novel transcriptional target of p53 protein activated by non-genotoxic stress, Journal of Biological Chemistry, vol.291, issue.32, pp.16586-16596, 2016. ,
P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest, Cell Death & Disease, vol.6, issue.10, p.10, 2015. ,
Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2, Cell Death & Differentiation, vol.25, issue.5, pp.841-856, 2018. ,
-ceramide is a natural regulatory ligand of p53 in cellular stress response, Nature Communications, 2018. ,
Folate stress induces apoptosis via p53-dependent de Novo ceramide synthesis and up-regulation of ceramide synthase 6, Journal of Biological Chemistry, vol.288, issue.18, pp.12880-12890, 2013. ,
Iron and cancer: more ore to be mined, Nature Reviews Cancer, vol.13, issue.5, pp.342-355, 2013. ,
Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53, British Journal of Haematology, vol.138, issue.2, pp.253-262, 2007. ,
Regulation of iron homeostasis bythe p53-ISCU pathway, Scientific Reports, vol.2, issue.5, p.16497, 2015. ,
Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells, Nature Medicine, vol.7, issue.10, pp.1111-1117, 2001. ,
The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis, Oncogene, vol.21, issue.47, pp.7195-7204, 2002. ,
p53 directly regulates the transcription of the human frataxin gene and its lack of regulation in tumor cells decreases the utilization of mitochondrial iron, Gene, vol.551, issue.1, pp.79-85, 2014. ,
Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis, American Journal Of Pathology, vol.176, issue.2, pp.1006-1017, 2010. ,
Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha, Nature, vol.392, issue.6674, pp.405-408, 1998. ,
Iron chelator-mediated alterations in gene expression: identification of novel ironregulated molecules that are molecular targets of hypoxia-inducible factor-1 and p53, Molecular Pharmacology, vol.77, issue.3, pp.443-458, 2010. ,
Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulationof p53 localization, stability, and function, Cell Reports, vol.7, issue.1, pp.180-193, 2014. ,
Ferritin binds and activates p53 under oxidative stress, Biochemical and Biophysical Research Communications, vol.389, issue.3, pp.399-404, 2009. ,
p53 tumor suppressor and iron homeostasis, FEBS Journal, vol.286, issue.4, pp.620-629, 2018. ,
Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2, Genes & Development, vol.31, issue.12, pp.1243-1256, 2017. ,
Silencing of frataxin gene expression triggers p53-dependent apoptosis in human neuronlike cells, Human Molecular Genetics, vol.20, issue.14, pp.2807-2822, 2011. ,
Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence, Cell, vol.149, issue.6, pp.1269-1283, 2012. ,
Ferroptosis as a p53-mediated activity during tumor suppression, Nature, vol.520, issue.7545, pp.57-62, 2015. ,
Acetylation is crucial for p53-mediated ferroptosis and tumor suppression, Cell Reports, vol.17, issue.2, pp.366-373, 2016. ,
Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53, EMBO Reports, p.47563, 2019. ,
ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway, Nature Cell Biology, vol.21, issue.5, pp.579-591, 2019. ,
Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses, Proceedings of the National Academy of Sciences, vol.113, issue.44, pp.6806-6812, 2016. ,
An African-specific polymorphism in the TP53gene impairs p53 tumor suppressor function in a mouse model, Genes & Development, vol.30, issue.8, pp.918-930, 2016. ,
The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity, Cell Reports, vol.20, issue.7, pp.1692-1704, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01581142
p53 suppresses metabolic stress-induced ferroptosis in cancer cells, Cell Reports, vol.22, issue.3, pp.569-575, 2018. ,
AMP-Activated Protein Kinase induces a p53-dependent Metabolic checkpoint, Molecular Cell, vol.18, issue.3, pp.283-293, 2005. ,
The B55a subunit of PP2A Drivesa p53-dependent metabolic adaptation to glutamine deprivation, Molecular Cell, vol.50, issue.2, pp.200-211, 2013. ,
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells, Nature, vol.493, issue.7433, pp.542-546, 2013. ,
A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3, Cell Metabolism, vol.28, issue.5, pp.721-736, 2018. ,
p53 promotes cancer cell adaptation to glutamine deprivation by upregulating Slc7a3 to increase arginine uptake, Cell Reports, vol.26, issue.11, pp.3051-3054, 2019. ,
p53 protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation, Journal of Biological Chemistry, vol.290, issue.1, pp.457-466, 2015. ,
Chromatin-bound MDM2 regulates serine metabolism and redox homeostasis independently of p53, Molecular Cell, vol.62, issue.6, pp.890-902, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01886397
Proline metabolism in cell regulation and cancer biology: recent advances and hypotheses, Antioxidants and Redox Signaling, vol.30, issue.4, pp.635-649, 2019. ,
Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses, Journal of Human Genetics, vol.49, issue.3, pp.134-140, 2004. ,
A model for p53-induced apoptosis, Nature, vol.389, issue.6648, pp.300-305, 1997. ,
P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements, PLoS One, vol.8, issue.7, p.69152, 2013. ,
A global map of p53 transcription-factor binding sites in the human genome, Cell, vol.124, issue.1, pp.207-219, 2006. ,
Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species, Cancer Research, vol.61, issue.5, pp.1810-1815, 2001. ,
Proline dehydrogenase promotes senescence through the generation of reactive oxygen species, Journal of Cell Science, vol.130, issue.8, pp.1413-1420, 2017. ,
SKN-1 and Nrf2 couples proline catabolism with lipid metabolism during nutrient deprivation, Nature Communications, vol.5, p.5048, 2014. ,
p53 regulation of ammonia metabolism throughurea cycle controls polyamine biosynthesis, Nature, vol.567, issue.7747, pp.253-256, 2019. ,
A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH, Biochemical and Biophysical Research Communications, vol.418, issue.4, pp.682-688, 2012. ,
Proteomic Analysis Reveals GMP Synthetase as p53 repression taarget in liver cancer, American Journal Of Pathology, vol.187, issue.2, pp.228-235, 2017. ,
Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization, Molecular Cell, vol.53, issue.3, pp.458-470, 2014. ,
Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage, Nucleic Acids Research, vol.37, issue.1, pp.78-95, 2008. ,
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage, Nature, vol.404, issue.6773, pp.42-49, 2000. ,
A ribonucleotide reductase gene is a transcriptional target of p53 and p73, Oncogene, vol.19, issue.37, pp.4283-4289, 2000. ,
P53 suppresses ribonucleotide reductase via inhibiting mTORC1, Oncotarget, vol.8, issue.25, pp.41422-41431, 2017. ,
The antioxidant function of the p53 tumor suppressor, Nature Medicine, vol.11, issue.12, pp.1306-1313, 2005. ,
Delayed ageing through damage protection by the Arf/p53 pathway, Nature, vol.448, issue.7151, pp.375-379, 2007. ,
Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53, Proceedings of the National Academy of Sciences of the United States of America, vol.93, issue.6, pp.2442-2447, 1996. ,
p53-Induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis, Cancer Research, vol.64, issue.7, pp.2350-2356, 2004. ,
The critical role of catalase in prooxidant and antioxidant function of p53, Cell Death & Differentiation, vol.20, issue.1, pp.117-129, 2012. ,
A novel antioxidant function for the tumor-suppressor gene p53 in the retinal ganglion cell, Investigative Ophthalmology & Visual Science, vol.49, issue.10, pp.4237-4244, 2008. ,
PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes, Oncogene, vol.18, issue.1, pp.127-137, 1999. ,
Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability, Oncogene, vol.21, issue.39, pp.6017-6031, 2002. ,
p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling, Cell, vol.134, issue.3, pp.451-460, 2008. ,
Sestrins activate Nrf2 by promoting p62-dependent autophagic Degradationof Keap1 and prevent oxidative liver damage, Cell Metabolism, vol.17, issue.1, pp.73-84, 2013. ,
p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis, Molecular Cell, vol.8, issue.1, pp.85-94, 2001. ,
P53-dependent expression of the stress-induced protein (SIP), European Journal of Cell Biology, vol.81, issue.5, pp.294-301, 2002. ,
Absence of tumor suppressor tumor protein 53-induced nuclear protein 1 (TP53INP1) sensitizes mouse thymocytes and embryonic fibroblasts to redox-driven apoptosis, Antioxidants and Redox Signaling, vol.15, issue.6, pp.1639-1653, 2011. ,
The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense, Oncogene, vol.34, issue.14, pp.1799-1810, 2014. ,
Identification of NCF2/ p67phox as a novel p53 target gene, Cell Cycle, vol.11, issue.24, pp.4589-4596, 2014. ,
Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression, Journal of Biological Chemistry, vol.281, issue.31, pp.21698-21709, 2006. ,
p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense proteinmanganese superoxide dismutase, Cancer Research, vol.65, issue.9, pp.3745-3750, 2005. ,
A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis, Oncogene, vol.21, issue.24, pp.3872-3878, 2002. ,
Inhibition of mitochondrial fragmentation diminishes Huntington's diseaseeassociated neurodegeneration, Journal of Clinical Investigation, vol.123, issue.12, pp.5371-5388, 2013. ,
Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling, Journal of Biological Chemistry, vol.275, issue.21, pp.16202-16212, 2000. ,
Mitochondrial p53 activates Bak and causes disruption of a BakeMcl1 complex, Nature Cell Biology, vol.6, issue.5, pp.443-450, 2004. ,
p53 as a hub in cellular redox regulation and therapeutic target in cancer, Journal of Molecular Cell Biology, vol.11, issue.4, pp.330-341, 2019. ,
Redox control and interplay between p53 isoforms: roles in the regulation of basal p53 levels, cell fate, and senescence, Antioxidants and Redox Signaling, vol.15, issue.6, pp.1655-1667, 2011. ,
Redox regulation of p53, redox effectors regulated by p53: a subtle balance, Antioxidants and Redox Signaling, vol.16, issue.11, pp.1285-1294, 2012. ,
PML is a ROS sensor activating p53 upon oxidative stress, Journal of Experimental Medicine, vol.214, issue.11, pp.3197-3206, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02348554
Promyelocytic leukemia protein, a protein at the crossroad of oxidative stress and metabolism, Antioxidants and Redox Signaling, vol.26, issue.9, pp.432-444, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02441961
PML is a direct p53 target that modulates p53 effector functions, Molecular Cell, vol.13, issue.4, pp.523-535, 2004. ,
, Cell, vol.149, issue.7, pp.1536-1548, 2012.
ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy, Molecular Cancer, vol.9, issue.1, p.95, 2010. ,
Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell death, Cell Death & Differentiation, vol.18, issue.10, pp.1598-1607, 2011. ,
DRAM, a p53-induced modulator of autophagy, is critical for apoptosis, Cell, vol.126, issue.1, pp.121-134, 2006. ,
dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53, Oncogene, vol.24, issue.8, pp.1461-1466, 2004. ,
The coordinate regulation of the p53 and mTOR pathways in cells, Proceedings of the National Academy of Sciences of the United States of America, vol.102, issue.23, pp.8204-8209, 2005. ,
Regulation of autophagy by cytoplasmic p53, Nature Cell Biology, vol.10, issue.6, pp.676-687, 2008. ,
The effects of p53 on whole organism longevity are mediated by autophagy, Autophagy, vol.4, issue.7, pp.870-873, 2014. ,
Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress, Science, vol.336, issue.6078, pp.225-228, 2012. ,
Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer, Cancer Discovery, vol.3, issue.8, pp.894-907, 2013. ,
Autophagy suppresses progression of K-rasinduced lung tumors to oncocytomas and maintains lipid homeostasis, Genes & Development, vol.27, issue.13, pp.1447-1461, 2013. ,
p53 status determines the role of autophagy in pancreatic tumour development, Nature, vol.504, issue.7479, pp.296-300, 2013. ,
Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress, Journal of Biological Chemistry, vol.283, issue.7, pp.3979-3987, 2008. ,
Cell cycle regulation via p53 phosphorylation by a 5 0 -AMP activated protein kinase activator, 5-aminoimidazole-4-Carboxamide-1-b-Ribofuranoside, in a human hepatocellular carcinoma cell line, Biochemical and Biophysical Research Communications, vol.287, issue.2, pp.562-567, 2001. ,
Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis, Molecular and Cellular Biology, vol.30, issue.24, pp.5787-5794, 2010. ,
The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways, Cancer Research, vol.67, issue.7, pp.3043-3053, 2007. ,
Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53, Cancer, vol.120, issue.22, pp.3457-3468, 2014. ,
p53 maintains baseline expression of multiple tumor suppressor genes, Molecular Cancer Research, vol.15, issue.8, pp.1051-1062, 2017. ,
p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage, Journal of Biological Chemistry, vol.289, issue.7, pp.4083-4094, 2014. ,
REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species, Molecular Cell, vol.10, issue.5, pp.995-1005, 2002. ,
Regulation of PTEN transcription by p53, Molecular Cell, vol.8, issue.2, pp.317-325, 2001. ,
Induction of the growth inhibitor IGF-binding protein 3 by p53, Nature, vol.377, issue.6550, pp.646-649, 1995. ,
PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt, Cell, vol.136, issue.3, pp.535-550, 2009. ,
Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer, Cancer Research, vol.56, issue.12, pp.2781-2788, 1996. ,
Phosphorylation of HDM2 by Akt, Oncogene, vol.21, issue.13, pp.1955-1962, 2002. ,
HER-2/ neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation, Nature Cell Biology, vol.3, issue.11, pp.973-982, 2001. ,
Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function, Journal of Biological Chemistry, vol.278, issue.16, pp.13595-13598, 2003. ,
Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation, Cancer Research, vol.59, issue.24, pp.6046-6051, 1999. ,
p38 mitogenactivated protein kinase mediates hypoxic regulation of Mdm2 and p53 in Neurons, Journal of Biological Chemistry, vol.277, issue.25, pp.22909-22914, 2002. ,
Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2, Cell Death & Differentiation, vol.14, issue.6, pp.1106-1116, 2007. ,
Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells, Molecular and Cellular Biology, vol.23, issue.20, pp.7083-7095, 2003. ,
Hypoxia links ATR and p53 through replication arrest, Molecular and Cellular Biology, vol.22, issue.6, pp.1834-1843, 2002. ,
Redox regulation of p53 during hypoxia, Oncogene, vol.19, issue.34, pp.3840-3848, 2000. ,
Regulation of proliferation-survival decisions during tumor cell hypoxia, Molecular and Cellular Biology, vol.18, issue.5, pp.2845-2854, 1998. ,
Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria, Cellular and Molecular Life Sciences, vol.76, issue.9, pp.1759-1777, 2019. ,
Reciprocal influence of the p53 and the hypoxic pathways, Cell Death & Disease, vol.2, issue.5, p.11, 2011. ,
Regulation of cellular metabolism and hypoxia by p53, Cold Spring Harbor Perspectives in Medicine, vol.6, issue.7, p.26146, 2016. ,
Hypoxiamodified cancer cell metabolism, Frontiers of Cell & Developmental Biology, vol.7, p.4, 2019. ,
Genome-wide analysis of p53 under hypoxic conditions, Molecular and Cellular Biology, vol.26, issue.9, pp.3492-3504, 2006. ,
PCAF is an HIF-1a cofactor that regulates p53 transcriptional activity in hypoxia, Oncogene, vol.27, issue.44, pp.5785-5796, 2008. ,
Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation, Molecular and Cellular Biology, vol.21, issue.4, pp.1297-1310, 2001. ,
p53 mediates autophagy and cell death by a mechanism contingent on Bnip3, Hypertension, vol.62, issue.1, pp.70-77, 2013. ,
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth, Cancer Cell, vol.6, issue.6, pp.597-609, 2004. ,
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation, The EMBO Journal, vol.21, issue.22, pp.6236-6245, 2002. ,
Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases, Molecular Cell, vol.8, issue.6, pp.1243-1254, 2001. ,
HDAC8 regulates long-term hematopoietic stem-cell maintenance under stress by modulating p53 activity, Blood, vol.130, issue.24, pp.2619-2630, 2017. ,
Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8, Oncogene, vol.32, issue.5, pp.599-609, 2012. ,
Regulation of cellular metabolism by protein lysine acetylation, Science, vol.327, issue.5968, pp.1000-1004, 2010. ,
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey, Molecular Cell, vol.23, issue.4, pp.607-618, 2006. ,
NADþ Modulates p53 DNA Binding Specificity and cellular reprogramming, Molecular and Cellular Biology, vol.24, issue.22, pp.9958-9967, 2004. ,
Role of Sirtuin 1-p53 regulatory axis in aging, cancer and Ageing, Ageing Research Reviews, vol.43, pp.64-80, 2018. ,
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice, Proceedings of the National Academy of Sciences of the United States of America, vol.100, pp.10794-10799, 2003. ,
SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization, Cell Stem Cell, vol.2, issue.3, pp.241-251, 2008. ,
Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux, Proceedings of the National Academy of Sciences of the United States of America, vol.103, issue.5968, pp.10230-10235, 2010. ,
Nutrient availability regulates SIRT1 through a forkhead-dependent pathway, Science, vol.306, issue.5704, pp.2105-2108, 2004. ,
A single-nucleotide variation in a p53-binding site affects nutrient-sensitive human SIRT1 expression, Human Molecular Genetics, vol.19, issue.21, pp.4123-4133, 2010. ,
miR-34a repression of SIRT1 regulates apoptosis, Proceedings of the National Academy of Sciences, vol.105, issue.36, pp.13421-13426, 2008. ,
Telomere dysfunction induces sirtuin repression that drives telomere-dependent disease, Cell Metabolism, vol.29, issue.6, pp.1274-1279, 2019. ,
Telomere dysfunction induces metabolic and mitochondrial compromise, Nature, vol.470, issue.7334, pp.359-365, 2011. ,
PGC-1a, a key modulator of p53, promotes cell survival upon metabolic stress, Molecular Cell, vol.44, issue.4, pp.621-634, 2011. ,
p53 regulates expression of uncoupling protein 1 through binding and repression of PPARg coactivator-1a, American Journal of Physiology-Endocrinology and Metabolism, vol.310, issue.2, pp.116-128, 2016. ,
Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle, Physiological Genomics, vol.37, issue.1, pp.58-66, 2009. ,
Acute exercise induces tumour suppressor protein p53 translocation to the mitochondria and promotes a p53-Tfammitochondrial DNA complex in skeletal muscle, The Journal of Physiology, vol.591, issue.14, pp.3625-3636, 2013. ,
Exercise-induced mitochondrial p53 repairs mtDNA mutations in mutator mice, pp.1-18, 2016. ,
A systematic review of p53 regulation of oxidative stress in skeletal muscle, Redox Report, vol.23, issue.1, pp.100-117, 2018. ,
2017. p53 regulates the cardiac transcriptome, Proceedings of the National Academy of Sciences, vol.114, issue.9, pp.2331-2336 ,
p53's choice of myocardial death or survival: oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys 118acety-lation, EMBO Molecular Medicine, vol.5, issue.11, pp.1662-1683, 2013. ,
p53 as a Dichotomous regulator of liver disease: the dose makes the medicine, International Journal of Molecular Sciences, vol.19, issue.3, p.921, 2018. ,
Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis, The FASEB Journal, vol.31, issue.2, pp.732-742, 2017. ,
p53 involvement in the pathogenesis of fatty liver disease, Journal of Biological Chemistry, vol.279, issue.20, pp.20571-20575, 2004. ,
Relationship of p53 accumulation in peripheral tissues of high-fat dietinduced obese rats with decrease in metabolic and oncogenic signaling of insulin, General and Comparative Endocrinology, vol.214, pp.134-139, 2015. ,
Wild-type p53 promotes cancer metabolic switch by inducing PUMA-dependent suppression of oxidative phosphorylation, Cancer Cell, vol.35, issue.2, pp.191-198, 2019. ,
Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion, Proceedings of the National Academy of Sciences, vol.111, issue.29, pp.10684-10689, 2014. ,
p53-dependent regulation of metabolic function through transcriptional activation of pantothenate kinase-1 gene, Cell Cycle, vol.12, issue.5, pp.753-761, 2014. ,
p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production, Cancer & Metabolism, vol.1, issue.1, p.1, 2013. ,
Glucose tolerance in mice is linked to the dose of the p53 transactivation domain, Endocrine Research, issue.3, pp.139-150, 2012. ,
A new role of p53 in regulating lipid metabolism, Journal of Molecular Cell Biology, vol.5, issue.2, pp.147-150, 2013. ,
Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease, Journal of Hepatology, vol.58, issue.4, pp.785-791, 2013. ,
p53 regulates Caveolin gene transcription, cell cholesterol, and growth by a novel mechanism, Biochemistry, vol.39, issue.8, 2000. ,
p53 functions in adipose tissue metabolism and homeostasis, International Journal of Molecular Sciences, vol.19, issue.9, p.2622, 2018. ,
Guardian of corpulence: a hypothesis on p53 signaling in the fat cell, Clinical Lipidology, vol.4, issue.2, pp.231-243, 2009. ,
p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner, PLoS One, vol.3, issue.11, p.3707, 2008. ,
Role of p53 in preadipocyte differentiation, Cell Biology International, vol.38, issue.12, pp.1384-1393, 2014. ,
Inhibitory effect of p53 on mitochondrial content and function during adipogenesis, Biochemical and Biophysical Research Communications, vol.446, issue.1, pp.91-97, 2014. ,
p53 activation in adipocytes of obese mice, Journal of Biological Chemistry, vol.278, issue.28, pp.25395-25400, 2003. ,
p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity, Cell Death & Differentiation, vol.20, issue.5, pp.774-783, 2013. ,
Pharmacological and genetic manipulation of p53 in Brown fat at adult but not embryonic stages regulates thermogenesis and body weight in male mice, Endocrinology, vol.157, issue.7, pp.2735-2749, 2016. ,
Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects, Oncotarget, vol.9, issue.7, pp.7282-7297, 2018. ,
Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner, Developmental Biology, vol.423, issue.1, pp.34-45, 2017. ,
Type 2 diabetes and congenital hyperinsulinism cause DNA Double-strand breaksand p53 activity in b cells, Cell Metabolism, vol.19, issue.1, pp.109-121, 2014. ,
Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic-cell function in diabetes, Proceedings of the National Academy of Sciences, vol.111, issue.8, pp.3116-3121, 2014. ,
Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice, Journal of Biological Chemistry, vol.287, issue.7, pp.5102-5111, 2012. ,
D40 isoform of p53 controls cell proliferation and glucose homeostasis in mice, Diabetes, vol.60, issue.4, pp.1210-1222, 2011. ,
The MDM2ep53epyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic, Nature Communications, vol.7, pp.1-14, 2016. ,
A crucial role for adipose tissue p53 in the regulation of insulin resistance, Nature Medicine, vol.15, issue.9, pp.1-7, 2009. ,
Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression, International Journal of Obesity, vol.38, issue.5, pp.737-745, 2014. ,
Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes, Diabetes, vol.57, issue.11, pp.3136-3144, 2008. ,
Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans, PLoS One, vol.6, issue.1, p.15813, 2011. ,
The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction, Cell Reports, vol.14, issue.10, pp.2413-2425, 2016. ,
NADPH oxidase 2-derived reactive oxygen species mediate FFAs-induced dysfunction and apoptosis of b-cells via JNK, p38 MAPK and p53 pathways, PLoS One, vol.5, issue.12, p.15726, 2010. ,
DNA damage and the activation of the p53 pathway mediate alterations in metabolic and secretory functions of adipocytes, Diabetes, vol.65, issue.10, pp.3062-3074, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01345698
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40, Acta Diabetologica, vol.50, issue.6, pp.899-906, 2013. ,
Inhibition of endothelial p53 ImprovesMetabolic abnormalities related to dietary obesity, Cell Reports, vol.7, issue.5, pp.1691-1703, 2014. ,
The central sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin, Diabetes, vol.60, issue.4, pp.1177-1185, 2011. ,
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression, Journal of Gastroenterology and Hepatology, vol.24, issue.3, pp.443-452, 2009. ,
p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice, Journal of Hepatology, vol.57, issue.4, pp.837-843, 2012. ,
Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease, World Journal of Gastroenterology, vol.12, issue.38, pp.6198-6202, 2006. ,
Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice, Journal of Clinical Investigation, vol.121, issue.8, pp.3343-3356, 2011. ,
Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis, Molecular Metabolism, vol.8, pp.132-143, 2018. ,
Emerging roles of p53 family members in glucose metabolism, International Journal of Molecular Sciences, vol.19, issue.3, p.776, 2018. ,
Metabolic pathways regulated by p63, Biochem Biophysic Res Commun, vol.482, issue.3, pp.440-444, 2017. ,
The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy, British Journal of Cancer, vol.116, issue.2, pp.149-155, 2016. ,
p53 is a transcriptional activator of the musclespecific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression, Cell Growth & Differentiation, vol.10, issue.5, pp.295-306, 1999. ,
The type II of hehokinase promoter contains funcionally active response elements for the tumor suppressor p53, Journal of Biological Chemistry, vol.272, issue.36, pp.22776-22780, 1997. ,
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity, Genome Research, vol.27, issue.10, pp.1645-1657, 2017. ,
Transcriptional activation of the human glutathione peroxidase promoter by p53, Journal of Biological Chemistry, vol.274, issue.17, pp.12061-12066, 1999. ,
Identification and cloning of EI24, a gene induced by p53 in etoposidetreated cells, Oncogene, vol.12, issue.6, pp.1181-1187, 1996. ,